NeuroKyma

Curated by Signal

Developer of EEG-based neuro markers for detecting brain activity

Overview

Developer of EEG-based neuro markers for detecting brain activity. The company specializes in the analysis of electrical brain signals, the electroencephalography (EEG), whether in cognitive or clinical neurosciences for quantifying brain disorders.

Key facts

Founded: 2020
Headquarters: France
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

CorteXx Medical Intelligence
Developer of artificial intellgience-based integrative medicine platforms for treating neural diseases
Life Sciences TechnologyFrance
Cardio Renal
Provider of digital therapeutics solutions for chronic kidney disease (CKD) management
Life Sciences TechnologyStrasbourg, France
Seenel Imaging
Developer of neuroimaging devices to manage neurological disorders
Life Sciences TechnologyAmiens, France

About NeuroKyma

What does NeuroKyma do?

Developer of EEG-based neuro markers for detecting brain activity.

Where is NeuroKyma headquartered?

NeuroKyma is headquartered in France.

When was NeuroKyma founded?

NeuroKyma was founded in 2020.

Which sector is NeuroKyma in?

NeuroKyma operates in Life Sciences Technology.

Who are NeuroKyma's competitors?

Companies similar to NeuroKyma include CorteXx Medical Intelligence, Cardio Renal, and Seenel Imaging.